Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Public Health. 2023 Feb 22;11:1119374. doi: 10.3389/fpubh.2023.1119374. eCollection 2023.
The incidence of kidney, bladder, and prostate cancer ranked ninth, sixth, and third in male cancers respectively, meanwhile, the incidence of testicular cancer also increased gradually in the past 30 years.
To study and present estimates of the incidence, mortality, and disability of kidney, bladder, prostate, and testicular cancer by location and age from 1990 to 2019 and reveal the mortality risk factors of them.
The Global Burden of Diseases Study 2019 was used to obtain data for this research. The prediction of cancer mortality and incidence was based on mortality-to-incidence ratios (MIRs). The MIR data was processed by logistic regression and adjusted by Gaussian process regression. The association between the socio-demographic index and the incidence or disease burden was determined by Spearman's rank order correlation.
Globally in 2019, there were 371,700 kidney cancer cases with an age-standardized incidence rate (ASIR) of 4.6 per 100,000, 524,300 bladder cancer cases, with an ASIR of 6.5 per 100,000, 1,410,500 prostate cancer cases with an ASIR of 4.6 per 100,000 and 109,300 testicular cancer incident cases with an ASIR of 1.4 per 100,000, the ASIR of these four cancers increased by 29.1, 4, 22, and 45.5% respectively. The incidence rate of the four cancers and the burden of kidney cancer were positively correlated with the socio-demographic index (SDI), regions with a higher SDI faced more of a burden attributable to these four cancers. High body-mass index has surpassed smoking to be the leading risk factor in the past thirty years for kidney cancer mortality. Smoking remained the leading risk factor for cancer-related mortality for bladder cancer and prostate cancer and the only risk factor for prostate cancer. However, the contribution of high fasting plasma glucose to bladder cancer mortality has been increasing.
The incidence of bladder, kidney, prostate, and testicular cancer is ever-increasing. High-income regions face a greater burden attributable to the four cancers. In addition to smoking, metabolic risk factors may need more attention.
在男性癌症中,肾癌、膀胱癌和前列腺癌的发病率分别位居第九、第六和第三位,同时,过去 30 年睾丸癌的发病率也逐渐上升。
研究并呈现 1990 年至 2019 年按位置和年龄划分的肾癌、膀胱癌、前列腺癌和睾丸癌的发病率、死亡率和残疾率,并揭示其死亡率的风险因素。
本研究使用 2019 年全球疾病负担研究的数据。癌症死亡率和发病率的预测是基于死亡率与发病率的比值(MIR)。MIR 数据通过逻辑回归进行处理,并通过高斯过程回归进行调整。社会人口指数与发病率或疾病负担之间的关联通过 Spearman 秩相关确定。
2019 年,全球有 371700 例肾癌病例,标准化发病率(ASIR)为每 10 万人 4.6 例,524300 例膀胱癌病例,ASIR 为每 10 万人 6.5 例,1410500 例前列腺癌病例,ASIR 为每 10 万人 4.6 例,109300 例睾丸癌新发病例,ASIR 为每 10 万人 1.4 例,这四种癌症的 ASIR 分别增长了 29.1%、4%、22%和 45.5%。这四种癌症的发病率和肾癌负担与社会人口指数(SDI)呈正相关,SDI 较高的地区面临着更大的这四种癌症负担。高身体质量指数(BMI)已超过吸烟,成为过去 30 年来导致肾癌死亡的主要风险因素。吸烟仍然是膀胱癌和前列腺癌相关死亡率的主要风险因素,也是前列腺癌的唯一风险因素。然而,高空腹血糖对膀胱癌死亡率的贡献一直在增加。
膀胱癌、肾癌、前列腺癌和睾丸癌的发病率呈上升趋势。高收入地区面临着更大的这四种癌症负担。除了吸烟,代谢风险因素可能需要更多关注。